Learn More
Medchemexpress LLC Flumatinib-d3 | >98% | 565.61 | 1 MG

Supplier: Medchemexpress LLC HY13904S1MG
Flumatinib-d3 is deuterium labeled Flumatinib. Flumatinib (HHGV678) is an orally available, selective inhibitor of Bcr-Abl. Flumatinib inhibits c-Abl, PDGFRβ, and c-Kit with IC50s of 1.2 nM, 307.6 nM, and 665.5 nM, respectively.
- Deuterium labeled Flumatinib
- Orally available
- Selective inhibitor of Bcr-Abl
- Inhibits c-Abl with IC50 of 1.2 nM
- Inhibits PDGFRβ with IC50 of 307.6 nM
- Inhibits c-Kit with IC50 of 665.5 nM
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.